I have made the following point recently. I believe that the quickest path to cash flow is via carotid
vascular work. there must be 100 vascular surgeons in Australia who should do 5 carotid jobs per week each public and private( school fees are very high). Thats 25000 per annum , 10,000 may require a patch. Extrapolate this figure world wide and its staggering. The present dacron graft is not great to work with and a vein graft is time consuming to harvest and is another source of bleeding.
Yet we do not have approval here nor in theEU for this work. Why not? The carotid and kidney renal shunts will pave the way and finance this company initially and quickly. The aortic valve story is great but 2 years away. Most LT investors could wait for that if the other cash flow was flowing.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus to host Investor Webinar
Ann: Admedus to host Investor Webinar, page-42
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M |
Open | High | Low | Value | Volume |
$18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60 | $17.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.05 | 554 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 17.880 |
1 | 47 | 17.870 |
1 | 619 | 17.860 |
1 | 37 | 17.650 |
2 | 700 | 17.550 |
Price($) | Vol. | No. |
---|---|---|
18.050 | 554 | 1 |
18.100 | 1000 | 1 |
18.200 | 343 | 2 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online